Your browser doesn't support javascript.
loading
EIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinoma.
Cha, Yin-Lian; Li, Pin-Dong; Yuan, Lin-Jing; Zhang, Mei-Yin; Zhang, Yao-Jun; Rao, Hui-Lan; Zhang, Hui-Zhong; Zheng, X F Steven; Wang, Hui-Yun.
Afiliação
  • Cha YL; State Key Laboratory of Oncology in Southern China, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China; National Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China.
  • Li PD; State Key Laboratory of Oncology in Southern China, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China; National Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China.
  • Yuan LJ; State Key Laboratory of Oncology in Southern China, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China; National Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China.
  • Zhang MY; State Key Laboratory of Oncology in Southern China, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China; National Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China.
  • Zhang YJ; Department of Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China.
  • Rao HL; Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China.
  • Zhang HZ; Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China.
  • Zheng XF; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey, United States of America.
  • Wang HY; State Key Laboratory of Oncology in Southern China, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China; National Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China.
PLoS One ; 10(2): e0117493, 2015.
Article em En | MEDLINE | ID: mdl-25658620

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Carcinoma Hepatocelular / Proteínas Adaptadoras de Transdução de Sinal / Neoplasias Hepáticas Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Carcinoma Hepatocelular / Proteínas Adaptadoras de Transdução de Sinal / Neoplasias Hepáticas Idioma: En Ano de publicação: 2015 Tipo de documento: Article